Varex Imaging Corporation Common Stock · Technology · Electronic Equipment
As of 2026-06-26, Varex Imaging Corporation Common Stock (VREX) has a 3-month relative strength percentile of 32 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 48. The current market Stance is 47 (Neutral). Sector: Technology, ranked 1 of 11. Average daily range 5.0%, relative volume 4.51×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
32 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
VREX is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -4.4% / -12.6%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
VREX is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $14M notional. Top 3 carry $30M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $14M |
| IWMiShares Russell 2000 ETF | 0.02% | $11M |
| VXFVanguard Extended Market ETF | 0.01% | $5M |
| XHEState Street SPDR S&P Health Care Equipment ETF | 0.56% | $750K |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $550K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VREX Jan avg: 3.42% median: 0.02% win: 50% σ: 12.16% n: 4 2022-04-12 → 2026-05-29 | VREX Feb avg: -10.09% median: -8.57% win: 0% σ: 5.55% n: 4 2022-04-12 → 2026-05-29 | VREX Mar avg: -5.29% median: -3.49% win: 50% σ: 11.51% n: 4 2022-04-12 → 2026-05-29 | VREX Apr avg: -7.10% median: -4.34% win: 20% σ: 13.90% n: 5 2022-04-12 → 2026-05-29 | VREX May avg: 3.08% median: -4.92% win: 40% σ: 16.06% n: 5 2022-04-12 → 2026-05-29 | VREX Jun avg: 2.04% median: 1.14% win: 50% σ: 9.57% n: 4 2022-04-12 → 2026-05-29 (current) | VREX Jul avg: -3.15% median: -0.39% win: 50% σ: 8.88% n: 4 2022-04-12 → 2026-05-29 | VREX Aug avg: 5.53% median: -10.46% win: 25% σ: 35.74% n: 4 2022-04-12 → 2026-05-29 | VREX Sep avg: -0.34% median: -2.12% win: 50% σ: 5.59% n: 4 2022-04-12 → 2026-05-29 | VREX Oct avg: 1.27% median: 0.33% win: 50% σ: 7.44% n: 4 2022-04-12 → 2026-05-29 | VREX Nov avg: 6.63% median: 1.70% win: 50% σ: 14.04% n: 4 2022-04-12 → 2026-05-29 | VREX Dec avg: -1.88% median: -1.87% win: 50% σ: 8.94% n: 4 2022-04-12 → 2026-05-29 |